• Publications
  • Influence
The fate of 14C-labeled allergens injected intradermally into guinea pigs, namely picryl chloride (PCl*) and 2:4 dinitrochlorobenzene (DNCB*), was followed during the induction period of delayedExpand
  • 250
  • 11
  • PDF
Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus
The therapeutic effect of thalidomide in chronic discoid lupus erythematosus (CDLE) was studied in sixty patients who were followed up for 2 years. In fifty‐four patients (90%) a complete or markedExpand
  • 190
  • 5
Expression of surface antigens and its relation to parameters of malignancy in human malignant melanoma
SummaryHuman malignant melanoma cell lines were assayed for secretion of plasminogen activator (PA) and for growth in the nude mouse. It was observed that cell lines that were high producers of PAExpand
  • 19
  • 3
[Paraneoplastic dermatoses].
  • 18
  • 3
What is the 'true' function of skin?
Conventional textbook wisdom portrays the skin as an organ that literally enwraps whatever each of us stands for as a more or less functional, individual member of the mammalian species, and has itExpand
  • 215
  • 2
  • PDF
Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate.
The fate of the contact sensitizer fluorescein isothiocyanate was traced by means of fluorescence spectrophotometry and flow cytometry. The hapten applied to one ear rapidly entered the circulationExpand
  • 48
  • 2
In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Monoclonal antibodies, directed against functionally different lymphocyte subsets, were applied on frozen sections of primary malignant melanomas and benign nevi. Positive reaction was identified byExpand
  • 36
  • 2
Phenotypic dynamics of tumor progression in human malignant melanoma
The phenotypic changes in human melanoma cells during the course of tumor progression were studied with monoclonal antibodies (MAbs) against the melanoma‐associated antigens (MAA) M.2.2.4, H.2.8.10,Expand
  • 166
  • 1